Hydrochlorothiazide

From Self-sufficiency
Jump to: navigation, search
Hydrochlorothiazide
200px
200px
Systematic (IUPAC) name
6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide
Clinical data
Pregnancy
category
  • B (D if used to treat pregnancy-induced hypertension)
Routes of
administration
Oral (capsules, tablets, oral solution)
Legal status
Legal status
  • ℞ (Prescription only)
Pharmacokinetic data
Bioavailability Variably absorbed from GI tract
Metabolism does not undergo significant metabolism (>95% excreted unchanged in urine)[1]
Biological half-life 5.6-14.8 h
Excretion Primarily excreted unchanged in urine
Identifiers
CAS Number 58-93-5
ATC code C03AA03 (WHO)
PubChem CID 3639
ChemSpider 3513
Chemical data
Formula C7H8ClN3O4S2
Molar mass 297.74[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
  (verify)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Hydrochlorothiazide, abbreviated HCTZ, HCT, or HZT, is a first line diuretic drug of the thiazide class that acts by inhibiting the kidneys' ability to retain water. This reduces the volume of the blood, decreasing blood return to the heart and thus cardiac output and, by other mechanisms, is believed to lower peripheral vascular resistance. Hydrochlorothiazide is sold both as a generic drug and under a large number of brand names, including Apo-Hydro, Aquazide H, Dichlotride, Hydrodiuril, HydroSaluric, Microzide, Esidrex, and Oretic.

Hydrochlorothiazide is also used in combination with many popular drugs used to treat hypertension such as Diovan HCT, Zestoretic, Benicar HCT, Atacand HCT, and Lotensin HCT, Temax-H and others.

Mechanism of action

Hydrochlorothiazide belongs to the thiazide class of diuretics, acting on the kidneys to reduce sodium (Na) reabsorption in the distal convoluted tubule. The major site of action in the nephron appears on an electroneutral Na+-Cl- co-transporter by competing for the chloride site on the transporter. By impairing Na transport in the distal convoluted tubule, hydrochlorothiazide induces a natriuresis and concomitant water loss. Thiazides increase the reabsorption of calcium in this segment in a manner unrelated to sodium transport. [2].

Indications

HCTZ is often used in the treatment of hypertension, congestive heart failure, symptomatic edema and the prevention of kidney stones. It is effective for nephrogenic diabetes insipidus and is also sometimes used for hypercalciuria, Dent's disease and Ménière's disease. For diabetes insipidus, the effect of thiazide diuretics is presumably mediated by a hypovolemia-induced increase in proximal sodium and water reabsorption, thereby diminishing water delivery to the ADH-sensitive sites in the collecting tubules and reducing the urine output.

Hypokalemia, an occasional side effect, can be usually prevented by potassium supplements or by combining hydrochlorothiazide with a potassium-sparing diuretic.

Thiazides are also used in the treatment of osteoporosis. Thiazides decrease mineral bone loss by promoting calcium retention in the kidney, and by directly stimulating osteoblast differentiation and bone mineral formation.[3]

Side effects

Please Note - you may experience an allergic reaction to this medication if you are allergic to sulfa drugs.

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links

de:Hydrochlorothiazid

es:Hidroclorotiazida fa:هیدروکلروتیازید hr:Hidroklorotiazid it:Idroclorotiazide hu:Hidroklorotiazid nl:Hydrochloorthiazide ja:ヒドロクロロチアジド no:Hydroklortiazid nn:Hydroklortiazid pl:Hydrochlorotiazyd pt:Hidroclorotiazida ru:Гидрохлоротиазид

sv:Hydroklortiazid
  1. Beermann B, Groschinsky-Grind M, Rosén A. (1976). "Absorption, metabolism, and excretion of hydrochlorothiazide". Clin Pharmacol Ther. 19 (5 (Pt 1)): 531–7. 
  2. Uniformed Services University Pharmacology Note Set #3 2010, Lectures #39 & #40, Eric Marks
  3. Dvorak MM, De Joussineau C, Carter DH; et al. (2007). "Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone". J. Am. Soc. Nephrol. 18 (9): 2509–16. doi:10.1681/ASN.2007030348. PMC 2216427Freely accessible. PMID 17656470.